|
Status |
Public on Sep 20, 2011 |
Title |
BT474_DMSO_24-1 |
Sample type |
RNA |
|
|
Source name |
BT474 breast cancer cell line, DMSO
|
Organism |
Homo sapiens |
Characteristics |
cell line: BT474 cell type: breast cancer lapatinib sensitivity: lapatinib-sensitive her2 status: HER2-positive treatment: DMSO
|
Treatment protocol |
Cells were treated with vehicle (DMSO), 1 µM lapatinib, 0.1 µM GSK1363089 (foretinib) or a combination of 1µM lapatinib and 0.1 µM foretinib for 24h.
|
Growth protocol |
Cells were plated in RPMI medium containing 10% FBS overnight at 37ºC, 5%CO2.
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol extraction of total RNA was performed according to the manufacturer's instructions.
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA were prepared according to the standard Affymetrix protocol (Response Genetics, Inc.)
|
|
|
Hybridization protocol |
Experiment conducted at Response Genetics, Inc.
|
Scan protocol |
Experiment conducted at Response Genetics, Inc.
|
Description |
Gene expression data of a breast cancer cell line.
|
Data processing |
RNA microarray signals were normalized by MAS5. QC and data analysis were performed using Omicsoft microarray analysis tools (http://www.omicsoft.com/).
|
|
|
Submission date |
Sep 20, 2011 |
Last update date |
Sep 20, 2011 |
Contact name |
Yuan Liu |
Fax |
610-917-5000
|
Organization name |
GlaxoSmithKline
|
Department |
Biomarker
|
Street address |
1250 South Collegeville Rd
|
City |
Collegeville |
State/province |
PA |
ZIP/Postal code |
19446 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE16179 |
BT474 and BT474-J4 microarray data |
|